Hi Susma, that would be very helpful, look forward to your answers.
-
-
Hi again,
I checked my journal. It was rRNA contamination and I realized that the rRNA depletion kit using was not so efficient. I switched to Ribo-Zero kit and I got nice depletion afterwards and nice libraries.
If you want to make sure that you have the same problem or not, just run your RNA input on bioanalyzer. Then if you see the rRNA peaks (even small), it shows that you have the same problem.
Be careful that you are not overloading RNA when you are using Ribo-Zero kit for depletion. Otherwise, you will see the same spikes in your library traces.
I hope you get over this
SusmaComment
-
Many thanks for the information Susma, we were using old Turbo DNAse and RiboZero kits, so this may have resulted in less rRNA depletion, or maybe all DNA was not removed which can result in poor RiboZero performance. Anyway, good to know and we will check on Bioanalyzer for rRNA contamination.
Bruce.Comment
-
Just FYI: My bioanalyzer traces looked exactly like this using the same kit. I ran the libraries on a gel and it pretty much replicated the bioanalyzer. Then I took two uL of each library and boiled it in 6uL FA dye to denature the sample and ran in on a 2% TBE gel. The upper bands disappeared and I got a nice smear from ~200-~600 bp. Maybe those spikes are the adaptor annealing products? (I did 14 cycles PCR and started with ~100ng RNA).Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...Yesterday, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment